Patients with Type 2 diabetes who were prescribed SGLT2
inhibitors lost more weight than patients who received GLP-1
receptor agonists, according to a UB-led study.
Patients with Type 2 diabetes who were prescribed SGLT2
inhibitors lost more weight than patients who received GLP-1
receptor agonists, according to a UB-led study.
Copyright © 2024 | WordPress Theme by MH Themes